4:12Long-form

Glaxo CEO: Game-Changing HIV Drugs Are on the Way

United StatesPublished July 28, 2016

Views 4.55K  |  Likes 86  |  Comments 0
Views#1,781,303Global
Views#338,499United States

Channel

Bloomberg OriginalsBloomberg Originals
5.14M subs49.4K videosMar 2006

At a glance

Views

4,551

Likes

86

Comments

0

Performance vs. channel

Outlier score

Engagement rate

Revenue estimate

Details →

Total (all-time): $3 – $9

Based on estimated $0.7–$2 CPM.

About

July 27 -- GlaxoSmithKline CEO Andrew Witty discusses the company's earnings, products, growth and performance. He speaks on "Bloomberg ‹GO›." (Corrects to remove incorrect on-screen graphic)

Published
July 28, 2016
Made for kids
No

More features coming

We're working on new analytics and tools. Stay tuned.